STSN (Stemsation International) Current Deferred Revenue: $0.00 Mil (As of Sep. 2011)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Stemsation International Current Deferred Revenue?

Stemsation International STSN +20.87% Current Deferred Revenue is $0.00 Mil as of Sep. 2011.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Stemsation International's current deferred revenue for the quarter that ended in Sep. 2011 was $0.00 Mil.

Stemsation International Current Deferred Revenue Related Terms

Stemsation International Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Stemsation International's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stemsation International Current Deferred Revenue Chart

Stemsation International Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10
Current Deferred Revenue
0.00 0.00 0.00 0.00 0.00

Stemsation International Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
What does a Current Deferred Revenue of $0.00 Mil mean?
Stemsation International (STSN) has a Current Deferred Revenue of $0.00 Mil as of Sep. 2011. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Stemsation International and its competitors.
Is Stemsation International's Current Deferred Revenue too high?
Stemsation International's current Current Deferred Revenue is $0.00 Mil.
How does Stemsation International's Current Deferred Revenue compare to MAMP and LODE?
Stemsation International's Current Deferred Revenue of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Drug Manufacturers company?
A good Current Deferred Revenue depends on the Drug Manufacturers industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Stemsation International and its competitors. Stemsation International's current Current Deferred Revenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stemsation International stock overvalued right now?
Stemsation International (STSN) has a current Current Deferred Revenue of $0.00 Mil. The current Current Deferred Revenue is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Stemsation International (STSN), the current Current Deferred Revenue is $0.00 Mil as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Stemsation International Business Description

Address 9555 Bergamot Street, Lake Worth, FL, USA, 33467
Stemsation International Inc is developing a line of canned, flavored oxygen products to be sold business-to-business (B2B) and direct to consumers (DTC). These products will be distributed to the beverage industry, as well as to restaurants and bars. It is also developing R&D and manufacturing relationships for additional products and services.